Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FY23G
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,532
Award facts
- Contract value 100% obligated
- $7,531.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on September 12, 2025, with an ultimate completion date of October 3, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract involves no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal pharmaceutical procurement market despite its small business status.
DMS Pharmaceutical Group holds a significant single-award IDC with the DLA under the SPE2DB program valued at $499,999,999 and valid through November 2026, which serves as the vehicle for issuing firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities worldwide. As a longstanding federal contractor registered in SAM.gov since 2001, the company maintains a robust portfolio supplying branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. This delivery order for EXPAREL, a local anesthetic pharmaceutical product, exemplifies DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FY23G?
SPE2DB25FY23G was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FY23G worth?
The government has obligated $7,532 on SPE2DB25FY23G.
Is contract SPE2DB25FY23G an order under another contract?
Yes. SPE2DB25FY23G is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY23G competed?
The extent of competition for SPE2DB25FY23G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award